Abstracts of the HIV Research for Prevention Meeting, HIVR4P, 17-20 October, 2016, Chicago, USA
2016; Mary Ann Liebert, Inc.; Volume: 32; Issue: S1 Linguagem: Inglês
10.1089/aid.2016.5000.abstracts
ISSN1931-8405
Tópico(s)HIV Research and Treatment
ResumoAIDS Research and Human RetrovirusesVol. 32, No. S1 AbstractsFree AccessAbstracts of the HIV Research for Prevention Meeting, HIVR4P, 17-20 October, 2016, Chicago, USAPublished Online:1 Oct 2016https://doi.org/10.1089/aid.2016.5000.abstractsAboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail PROGRAM AT A GLANCEMonday, 17 OctoberTuesday, 18 OctoberWednesday, 19 OctoberThursday, 20 OctoberFriday, 21 OctoberSatellites08:30 – 15:00See pages 15-25 in the Program Book for times and information on the Satellite Sessions, presented on Monday, 17 October and Friday, 21 October.Plenary Session 02 08:30 – 10:00Unravelling the Mysteries of HIV Transmission (PL02)Sheraton Chicago Ballroom IV - VII, Ballroom LevelPlenary Session 03 08:30 – 10:00Which Way Is Forward: Emerging Challenges and Opportunities (PL03)Sheraton Chicago Ballroom IV - VII, Ballroom LevelNon-Abstract Driven Sessions 08:30 – 10:00Combinations and Keys: The Complexities and Successes of Reaching the People Who Need It (RT03) Chicago Ballroom VI - VII, Ballroom LevelGetting It Right: The Journey from Discovery to Impact (RT04)Chicago Ballroom VIII - X, Ballroom LevelEntering the Dark Zone: Germinal Centers in Immune Response (SY07)Sheraton Ballroom II - III, Ballroom LevelEnvelope Structure and Broadly Neutralizing Antibodies (SY08) Sheraton Ballroom IV - V, Ballroom LevelSatellites08:30 – 12:00See pages 15-25 in the Program Book for times and information on the Satellite Sessions, presented on Monday, 17 October and Friday, 21 October Refreshment Break 10:00 – 10:30 Sheraton/Chicago Promenade, Ballroom LevelRefreshment Break 10:00 – 10:30 Sheraton/Chicago Promenade, Ballroom LevelRefreshment Break 10:00 – 10:30 Sheraton/Chicago Promenade, Ballroom Level Oral Abstract Sessions 10:30 – 12:00Antibody Epitopes: Connecting the Dots (OA01) Sheraton Ballroom II - III, Ballroom LevelCrossing the Border: Mechanisms of Mucosal Transmission (OA02) Sheraton Ballroom IV - V, Ballroom LevelPrEP Problems: Real and Imagined (OA03) Chicago Ballroom VI - VII, Ballroom LevelIt Takes Two to Tango: Host, Hormones and Drug Levels in the Mucosa (OA04) Chicago Ballroom VIII - X, Ballroom LevelOral Abstract Sessions 10:30 – 12:00HIV Antibodies: The Good, the Bad and the Ugly (OA09)Sheraton Ballroom II - III, Ballroom LevelBack to the Future: Optimizing the Cascade (OA10) Sheraton Ballroom IV - V, Ballroom LevelTesting Vaccine Concepts: Where the Rubber Hits the Road (OA11) Chicago Ballroom VI - VII, Ballroom LevelPipelines and Platforms for Prevention (OA12) Chicago Ballroom VIII - X, Ballroom LevelOral Abstract Sessions 10:30 – 12:00Cellular Immunity Matters! (OA17) Sheraton Ballroom II - III, Ballroom LevelThe Great Escape: Host-Virus Transmission Dynamics (OA18) Sheraton Ballroom IV - V, Ballroom LevelPassive Immunization: Instant Protection (OA19) Chicago Ballroom VI - VII, Ballroom LevelTrust But Verify: Understanding Adherence (OA20) Chicago Ballroom VIII - X, Ballroom Level Delegate Lunch 12:00 – 13:00 River Exhibit AB and Odyssey Boat, River LevelNetworking Lunch 12:00 – 13:00 Michigan and Superior Rooms, Meeting LevelDelegate Lunch 12:00 – 13:00 River Exhibit AB and Odyssey Boat, River LevelNetworking Lunch 12:00 – 13:00 Michigan and Superior Rooms, Meeting LevelDelegate Lunch 12:00 – 13:00 River Exhibit AB and Odyssey Boat, River LevelNetworking Lunch 12:00 – 13:00 Michigan and Superior Rooms, Meeting Level Oral Abstract Sessions 13:00 – 14:30Risky Business (OA05) Sheraton Ballroom II - III, Ballroom LevelOf Mice and (Wo)men: Pharmacokinetics/Pharmacodynamics of Novel Products (OA06) Sheraton Ballroom IV - V, Ballroom LevelThrough the Looking Glass: New Insights into Mucosal Biology (OA07) Chicago Ballroom VI - VII, Ballroom LevelA Sugar Coated Pill: Immunogenicity of Envelope (OA08) Chicago Ballroom VIII - X, Ballroom LevelOral Abstract Sessions 13:00 – 14:30Do Right to Do Well: Creating a Framework for Success (OA13) Sheraton Ballroom II - III, Ballroom LevelTeaching the Immune System New Tricks: Vaccine-Induced Immune Responses (OA14) Sheraton Ballroom IV - V, Ballroom LevelUnique and Essential: Mucosal Environment of the Female Reproductive Tract (OA15) Chicago Ballroom VI - VII, Ballroom LevelPrEP and the Real World (OA16) Chicago Ballroom VIII - X, Ballroom LevelOral Abstract Sessions 13:00 – 14:30Designer Envelopes for Fashionable Responses (OA21) Sheraton Ballroom II - III, Ballroom LevelHuman Vaccine Clinical Trials: Reality Check (OA22) Sheraton Ballroom IV - V, Ballroom LevelPower, Pleasure and Prevention (OA23) Chicago Ballroom VI - VII, Ballroom LevelPrevention: Think Global, Prevent Local (OA24) Chicago Ballroom VIII - X, Ballroom Level Refreshment Break 14:30 – 15:30 Sheraton/Chicago Promenade, Ballroom LevelRefreshment Break 14:30 – 15:30 Sheraton/Chicago Promenade, Ballroom LevelRefreshment Break 14:30-15:00 Sheraton/Chicago Promenade, Ballroom Level Meet the Experts 14:45 – 15:15 Chicago Ballroom VIII - X, Ballroom LevelMeet the Experts 14:45 – 15:15 Chicago Ballroom VIII - X, Ballroom LevelRapporteur Session 15:00 – 16:30 Sheraton Chicago Ballroom IV - VII, Ballroom Level Opening Plenary Session 0116:00 – 18:00Get It and Forget It: Long-Acting HIV Prevention (PL01)Sheraton Chicago Ballroom IV - VII, Ballroom LevelNon-Abstract Driven Sessions 15:30 – 17:00Vaccine-Induced Humoral Immunity (SY01) Chicago Ballroom VI - VII, Ballroom LevelThe Role of Mucosal Barriers and Targets in HIV Acquisition (SY02) Sheraton Ballroom IV - V, Ballroom LevelChoosing ARVs for Prevention: Ensuring and Measuring Effective Tissue Delivery (SY03) Chicago Ballroom VIII - X, Ballroom LevelAdolescents: Bodies, Brains and Behaviors (SY04) Sheraton Ballroom II - III, Ballroom LevelNon-Abstract Driven Sessions 15:30 – 17:00What is Sterilizing Immunity? (RT01) Chicago Ballroom VI - VII, Ballroom LevelThe PrEP Prevention Package: From Efficacy Studies to the Real World (RT02) Chicago Ballroom VIII - X, Ballroom LevelUsing ARVs and Antibodies for Long-Acting Prevention (SY05) Sheraton Ballroom IV - V, Ballroom LevelEffective Cellular Immune Reponses (SY06) Sheraton Ballroom II - III, Ballroom LevelClosing Plenary Session 04 16:30 – 18:30Bring It On: Delivering Combination Prevention (PL04) Sheraton Chicago Ballroom IV - VII, Ballroom Level Welcome Reception18:00 – 20:00Sheraton/Chicago Promenade, Ballroom LevelPoster Discussions 17:15 – 18:00Evaluation of Vaccine Concepts (PD01) Sheraton Ballroom IV - V, Ballroom LevelAlternative Antibody Functions (PD02) Sheraton Ballroom II - III, Ballroom LevelInnovation in Topical Delivery (PD03) Chicago Ballroom VI - VII, Ballroom LevelPrepping for PrEP (PD04) Chicago Ballroom VIII - X, Ballroom LevelPoster Discussions 17:15 – 18:00Pushing the Envelope (PD05) Sheraton Ballroom IV - V, Ballroom LevelGerminating Germline Antibodies (PD06) Chicago Ballroom VI - VII, Ballroom LevelReproductive Health and Prevention (PD07) Sheraton Ballroom II - III, Ballroom LevelEnter New Inhibitors (PD08) Chicago Ballroom VIII - X, Ballroom LevelKEYPL PlenaryRT RoundtableSY SymposiumPD Poster DiscussionOA Oral Abstract Poster Session 01 and Reception 18:00 – 19:30River Exhibit AB, River LevelPoster Session 02 and Reception 18:00 – 19:30River Exhibit AB, River Level HIVR4P 2016 PARTNERSThe HIVR4P conference would not be possible without the generous support of our conference partners.The following institutions have contributed significant in-kind support:HIVR4P 2016 is made possible in part by the generous support of the American people through 1 R13 AI122959-01 from the National Institutes of Health (NIH), and from the United States Agency for International Development (USAID). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services or USAID; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.CONTENTSProgram at a Glance 2Partner Recognition 3Conference Committees 5–7Conference Scholars 8–12PresentationsPlenary Sessions 13–17Non-Abstract Driven Sessions 18–35Oral Abstract Sessions: Tuesday, 18 October 36–59Oral Abstract Sessions: Wednesday, 19 October 60–83Oral Abstract Sessions: Thursday, 20 October 84–107Poster Discussions: Tuesday, 18 October 108–119Poster Discussions: Wednesday, 19 October 120–130Overview of Poster Topics 131Posters 132–409Author Index 410–427Certificate of Attendance 428ABBREVIATIONSLate Breaker AbstractLBLevelLNetworking LunchNLOral AbstractOAOral Poster DiscussionPDPlenaryPLPosterPRapporteurRPRoundtableRTSymposiumSYCONFERENCE COMMITTEESCONFERENCE CHAIRSThomas HopeNorthwestern University, United StatesJeanne MarrazzoUniversity of Alabama at Birmingham School of Medicine, United StatesLynn MorrisNational Institute for Communicable Diseases and University of the Witwatersrand, South AfricaNelly MugoKenya Medical Research Institute, KenyaPROGRAM ORGANIZING COMMITTEE MEMBERSMarcus AltfeldHeinrich Pette Institute, Leibniz-Institute for Experimental Virology, GermanyJintanat AnanworanichU.S. Military HIV Research Program, United StatesDan BarouchBeth Israel Deaconess Medical Center, Ragon Institute of MGH, MIT and Harvard, United StatesGina BrownOffice of AIDS Research, National Institutes of Health, United StatesSusan BuchbinderSan Francisco Department of Public Health, United StatesElizabeth BukusiKenya Medical Research Institute, KenyaKundai ChinyenzeInternational AIDS Vaccine Initiative, KenyaZ. Mike ChirenjeUniversity of Zimbabwe-University of California San Francisco Collaborative Research Program, ZimbabweMyron CohenUniversity of North Carolina, United StatesDavid CooperKirby Institute, University of New South Wales, AustraliaCarl DieffenbachNational Institute of Allergy and Infectious Diseases, NIH, United StatesMark FeinbergInternational AIDS Vaccine Initiative, United StatesGeoff GarnettBill & Melinda Gates Foundation, United StatesBarney GrahamVaccine Research Center, NIAID, NIH, United StatesBeatriz GrinsztejnOswaldo Cruz Foundation, BrazilScott HammerColumbia University, United StatesCatherine HankinsAmsterdam Institute for Global Health and Development, NetherlandsBarton HaynesDuke University, United StatesSharon HillierUniversity of Pittsburgh School of Medicine, United StatesEric HunterEmory University and Emory Vaccine Center, United StatesAnatoli KamaliInternational AIDS Vaccine Initiative, KenyaAngela KashubaUniversity of North Carolina, United StatesMilly KatanaMTN Community Working Group/Senior Support Services, UgandaWayne KoffHuman Vaccines Project, United StatesRaphael LandovitzUCLA Center for Clinical AIDS Research and Education, United StatesJean-Daniel LelièvreINSERM/VRI (University Paris-Est Créteil), FranceBonnie MathiesonOffice of AIDS Research, NIH, United StatesKen MayerThe Fenway Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, United StatesSheena McCormackMedical Research Council Clinical Trials Unit at University College London, United KingdomLyle McKinnonUniversity of Manitoba/Centre for the AIDS Programme of Research in South Africa (CAPRISA), Canada and South AfricaAndrew MujugiraDepartment of Global Health, University of Washington, UgandaThumbi Ndung'uUniversity of KwaZulu-Natal, South AfricaJim PickettInternational Rectal Microbicide Advocates, United StatesGita RamjeeHIV Prevention Research Unit, South African Medical Research Council, South AfricaHelen ReesRHI: Wits Reproductive Health and HIV Institute, South AfricaNina RussellBill & Melinda Gates Foundation, United StatesWilliam SchiefScripps Research Institute and International AIDS Vaccine Initiative, United StatesBarbara ShacklettUniversity of California, Davis, United StatesYiming ShaoNational Center for AIDS/STD Control and Prevention (NCAIDS), and Chinese Center for Disease Control and Prevention, ChinaRobin ShattockImperial College London, United KingdomWilliam SnowGlobal HIV Vaccine Enterprise, United StatesMorenike UkpongObafemi Awolowo University, NigeriaMitchell WarrenAVAC, United StatesKim WoodrowUniversity of Washington, United StatesNtando YolaDesmond Tutu HIV Foundation, South AfricaABSTRACT REVIEW COMMITTEEIn addition to the Program Organizing Committee, HIVR4P would like to thank the following individuals for reviewing abstracts.Alash'le AbimikuInstitute of Human Virology Nigeria, NigeriaTodd AllenHarvard University, United StatesGalit AlterRagon Institute of MGH, MIT and Harvard University, United StatesRama AmaraEmory University, United StatesJared BaetenUniversity of Washington, United StatesPrince BahatiInternational AIDS Vaccine Initiative, KenyaChristian BranderIrsiCaixa, SpainNomita ChandhiokIndian Council of Medical Research, IndiaRobert ChenCenters for Disease Control and Prevention, United StatesJosephine CoxInternational AIDS Vaccine Initiative, United StatesCynthia DerdeynEmory University, United StatesGustavo DoncelEastern Virginia Medical School, United StatesDaniel DouekVaccine Research Center, NIAID, NIH, United StatesPatricia FastInternational AIDS Vaccine Initiative, United StatesKevin FisherAVAC, United StatesKeith FowkeUniversity of Manitoba, CanadaNicole FrahmFred Hutchinson Cancer Research Center, United StatesHenry GabelnickEastern Virginia Medical School Emeritus, United StatesJ. Victor GarciaUniversity of North Carolina at Chapel Hill, United StatesPaul GoepfertUniversity of Alabama at Birmingham, United StatesTomas HankeUniversity of Oxford, United KingdomCraig HendrixJohns Hopkins University, United StatesWalid HeneineCenters for Disease Control and Prevention, United StatesBetsy HeroldAlbert Einstein College of Medicine/Montefiore Medical Center, United StatesStephen KentUniversity of Melbourne, AustraliaJerome KimInternational Vaccine Institute, KoreaCharles LaceyUniversity of York, United KingdomRoger Le GrandCEA, FranceYves LévyINSERM/VRI, FranceGeorge LewisInstitute of Human Virology, United StatesAmapola ManriqueGlobal HIV Vaccine Enterprise, United StatesJohn MascolaVaccine Research Center, NIAID, NIH, United StatesBenoît MasseUniversity of Montreal, CanadaBarbara MenschPopulation Council, United StatesNelson MichaelU.S. Military HIV Research Program, United StatesPenny MooreUniversity of the Witwatersrand, South AfricaJeremy NuttallInternational Partnership for Microbicides, United StatesJean PattersonOffice of AIDS Research, United StatesDorothy PattonUniversity of Washington, United StatesPunnee PitisuttithumVaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, ThailandDamian PurcellUniversity of Melbourne, AustraliaMerlin RobbU.S. Military HIV Research Program, United StatesHarriet RobinsonGeoVax Inc., United StatesLisa RohanUniversity of Pittsburgh, United StatesMorgane RollandU.S. Military HIV Research Program, Henry M. Jackson Foundation for the Advancement of Military Medicine, United StatesJoseph RomanoNWJ Group, United StatesRuth RuprechtTexas Biomed, United StatesJeffrey SafritInternational AIDS Vaccine Initiative, United StatesEric SandströmKarolinska Institutet, SwedenGabriella ScarlattiGlobal HIV Vaccine Enterprise, United StatesAlexandra SchuetzU.S. Army Medical Component of the Armed Forces Research Institute of the Medical Sciences, ThailandOlivier SchwartzInstitut Pasteur, FranceGuido SilvestriEmory University, United StatesJonathan StadlerUniversity of the Witwatersrand, South AfricaAlan StoneMEDSA Ltd, United KingdomHendrik StreeckInstitute for HIV Research, GermanyJim Tartagliasanofi pasteur, United StatesBargavi ThyagarajanGlobal HIV Vaccine Enterprise, United StatesCaroline TiemessenNational Institute for Communicable Diseases, South AfricaGeorgia TomarasDuke Human Vaccine Institute, United StatesAlexandra TrkolaUniversity of Zurich, SwitzerlandJim TurpinPrevention Sciences Program, DAIDS, NIAID, NIH, United StatesLut Van DammeBill & Melinda Gates Foundation, United StatesRonald VeazeyTulane National Primate Research Center, United StatesSteven WakefieldHIV Vaccine Trials Network, United StatesAnna-Lise WilliamsonUniversity of Cape Town, South AfricaAllen Zhiwei WuNanjing University Medical School, ChinaSusan Zolla-PaznerIcahn School of Medicine at Mount Sinai, United StatesCONFERENCE SECRETARIATGOVERNANCE: Global HIV Vaccine Enterprise, United StatesKristin MorrellFunders Relations OfficerGabriella ScarlattiScience DirectorBargavi ThyagarajanScience OfficerMark AurigemmaMedia ConsultantLOGISTICS: Conference Solutions, United StatesKate PorterPresidentCONFERENCE SCHOLARSIsaac AdejoAchieving Health Nigeria Initiative, NigeriaOladele AdeniyiWalter Sisulu University/East London Hospital Complex, South AfricaAdedayo AdeyemiHealthmatch International, NigeriaGabriel AdeyemoTexila American University School of Public Health, University of Central Nicaragua, GuyanaCollins AgabaThe AIDS Support Organisation (TASO), UgandaHeena AggarwalAll India Institute of Medical Sciences, IndiaWbeimar Aguilar-JimenezGrupo Inmunovirología, Universidad de Antioquia, ColombiaShubbir AhmedTranslational Health Science and Technology Institute (THSTI), IndiaCarolyne AkelloMU-JHU Research Collaboration, UgandaToyese AkinadePopulation Council, NigeriaMaureen AkoloUniversity of Manitoba/University of Nairobi–Kenya AIDS Control Project, KenyaYoann AldonImperial College London, United KingdomObiajulu Augustina AmuamuziamNew HIV Vaccine and Microbicides Advocacy Society (NHVMAS), NigeriaNeeti AnanthaswamyThe Catholic University of America, United StatesJoseph Anejo-okopiUniversity of Jos, NigeriaColin AnthonyUniversity of Cape Town, South AfricaKanchana AyyarNational Institute for Research in Reproductive Health, IndiaUbaldo BahemukaMedical Research Council/Uganda Virus Research Institute (UVRI), UgandaGabriela Baldeon VacaBoston University School of Medicine, United StatesAndrew BaninNew York University Langone Medical Center, United StatesShaun BarnabasUniversity of Cape Town, South AfricaAnna-Janina BehrensUniversity of Oxford, United KingdomAnna BlakneyUniversity of Washington, United StatesMelanie Bouvin-PleyINSERM U966, FranceCharles BrownInfectious Diseases Institute, UgandaWilliam Brown IIIHIV Center for Clinical and Behavioral Studies, Columbia University, United StatesSarah CalabreseYale School of Public Health, United StatesAnn CariasNorthwestern University, United StatesMariangela CavarelliCommissariat à L'énergie Atomique et aux Énergies Alternatives (CEA), FranceKingsley ChasangaMalawi Network of AIDS Service Organisations (MANASO), MalawiNarayanaiah CheedarlaNational Institute for Research in Tuberculosis, IndiaDeyan ChenNanjing University, ChinaJian ChenShanghai Public Health Clinical Center, Fudan University, ChinaRyan CheuUniversity of Washington, United StatesStanford ChimutimunzeveUniversity of Zimbabwe-University of California San Francisco School of Medicine, ZimbabweJonah ChingaGay and Lesbian Coalition of Kenya, KenyaDaniel ClaiborneRagon Institute of MGH, MIT and Harvard, United StatesUchenna Clifford OnonakuInternational Center for Advocacy on Rights to Health/Institute of Human Virology Nigeria, NigeriaNúria ClimentInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), SpainSmritee DabeeInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, South AfricaSupratik DasTranslational Health Science and Technology Institute (THSTI), IndiaJosé das Nevesi3S – Instituto de Investigação e Inovação em Saúde, University of Porto, PortugalSuprit DeshpandeTranslational Health Science and Technology Institute (THSTI), IndiaZanele DitseNational Institute for Communicable Diseases of the National Health Laboratory Service, South AfricaSara DizzellMcMaster University, CanadaSigcinile DlaminiUniversity of Cape Town, South AfricaBisheng DongNanjing University, ChinaClare DottWits Reproductive Health and HIV Institute, South AfricaCamille DucloyINSERM U1109, FMTS Université de Strasbourg, FranceFlorita DuruekeNew HIV Vaccine and Microbicides Advocacy Society, NigeriaGodfrey DzhivhuhoUniversity of Cape Town, South AfricaHanna EbnerInstitute of Medical Virology, University of Zurich, SwitzerlandJames EghagheEqual Health and Rights Access Advocacy Initiative, NigeriaElina El-BadryEmory University, United StatesAmaka EnemoNigeria Sex Workers Association, NigeriaRené Ghislain EssombaFaculty of Medicine and Biomedical Sciences, University of Yaoundé, CameroonJuliane EtimaMU-JHU Research Collaboration, UgandaOlubunmi FakunlePublic Health Department, NigeriaTeresa FilipowiczRwanda Zambia HIV Research Group, ZambiaAnna ForbesSelf-Employed, United StatesJoseph FrancicaNational Institutes of Health, United StatesJohannes GachUniversity of California Irvine, United StatesMaria Lucia Gallo VauletUniversidad de Buenos Aires, Facultad de Farmacia y Bioquimica, ArgentinaHoyam GamieldienUniversity of Cape Town, South AfricaLucy GhatiKELIN, KenyaAnna GibbsKarolinska Institutet, SwedenSerah GitomeKenya Medical Research Institute, KenyaChristopher GonelliPeter Doherty Institute for Infection and Immunity, University of Melbourne, AustraliaAleksandr GorinDavid Geffen School of Medicine at University of California, Los Angeles, United StatesEliza GovenderCentre for the AIDS Programme of Research in South Africa (CAPRISA), South AfricaMarielle GoyetteUniversity of Washington, United StatesSheila GrabMagee-Womens Research Institute, University of Pittsburgh School of Pharmacy, United StatesAnneke (Anna Christina) GroblerCentre for the AIDS Programme of Research in South Africa (CAPRISA), South AfricaAlberto GuardoInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), SpainClement HaeckQueen's University Belfast, United KingdomGoli HaidariImperial College London, United KingdomLylia HaniINSERM U955, Equipe16, FranceRushil HarryparsadUniversity of Cape Town, South AfricaCarolina HerreraImperial College London, United KingdomAnn HessellOregon Health & Science University, United StatesJonathon HimesDuke University, United StatesAlexandra HoaglandProjet San Francisco (PSF), RwandaMaria Pia HolgadoInstituto de Investigaciones Biomedicas en Retrovirus y SIDA, ArgentinaXintao HuNational Cancer Institute at Frederick, United StatesSamantha HumbyUniversity of Cape Town, South AfricaMarla HusnikFred Hutchinson Cancer Research Center/University of Washington, United StatesChiedu IfekanduPopulation Council, NigeriaAlexy InciarteHospital Clinic, SpainAndrea IntroiniKarolinska Institutet, SwedenElizabeth IrunguPartners in Health Research and Development/Jomo Kenyatta University of Agriculture and Technology, KenyaMichelle IsaacsInternational Partnership for Microbicides (IPM), South AfricaMargaret JaphetObafemi Awolowo University, NigeriaKunal JhunjhunwalaUniversity of Pittsburgh, United StatesAgricola JoachimMuhimbili University of Health and Allied Sciences, TanzaniaVineet JoagUniversity of Toronto, CanadaJeremiah JohnsonTreatment Action Group, United StatesKadryn KadasiaBoston University, United StatesJane KarongeLVCT Health, KenyaRobinson KarugaLVCT Health, KenyaChilufya KasandaTreatment Advocacy and Literacy Campaign, ZambiaSulaiman KawooyaAIDS Healthcare Foundation/Uganda Cares Masaka, Masaka Healthcare Centre, Masaka Regional Referral Hospital, UgandaBarbarah KawoozoUganda Virus Research Institute (UVRI)–International AIDS Vaccine Initiative (IAVI), UgandaAyesha KharsanyCentre for the AIDS Programme of Research in South Africa (CAPRISA), South AfricaElvis KidzeruUniversity of Cape Town, South AfricaHannah KingBurnet Institute, AustraliaJairus KipyegoPartners in Prevention–Moi University, KenyaMichael KiraguLVCT Health, KenyaPaul KitandweUganda Virus Research Institute (UVRI)–International AIDS Vaccine Initiative (IAVI), UgandaJéromine KlinglerUMRS_1109, FranceZamakayise KoseHuman Sciences Research Council, South AfricaEmily A. KrogstadUniversity of Washington, United StatesRajesh KumarTranslational Health Science and Technology Institute (THSTI), IndiaRajnish KumarIcahn School of Medicine at Mount Sinai, United StatesColin KunzweilerUniversity of Illinois at Chicago, United StatesSylvia KusemererwaMedical Research Council/Uganda Virus Research Institute (UVRI), UgandaMonica KuteesaMedical Research Council/Uganda Virus Research Institute (UVRI), UgandaJordan Kyongo KaranjaLVCT Health, KenyaFaatima LaherNelson R. Mandela School of Medicine, University of KwaZulu-Natal, South AfricaElise LandaisInternational AIDS Vaccine Initiative (IAVI), United StatesLorna LealHospital Clinic of Barcelona, SpainMarc-André LeBlancCanadian PrEP Working Group (CanPrEP), CanadaWen Shi LeeUniversity of Melbourne, AustraliaMaria LemosFred Hutchinson Cancer Research Center, United StatesMatthew LevyGeorge Washington University Milken Institute School of Public Health, United StatesFan LiChina Center for Disease Control, ChinaCheryl LouwMadibeng Centre for Research, South AfricaMaureen LubaCommunity of Sant Egidio, MalawiLameck LumuThe AIDS Support Organisation (TASO), UgandaLaura Lusike LunaniKAVI-Institute of Clinical Research, KenyaGladys MachariaImperial College London, United KingdomTaruna MadanNational Institute for Research in Reproductive Health, IndiaJulia MakindeImperial College London, United KingdomRacheal MandishoraUniversity of Zimbabwe College of Health Sciences, ZimbabweNtombikhona MaphumuloUniversity of KwaZulu-Natal, South AfricaEmmanuel Aubrey MargolinUniversity of Cape Town, South AfricaDanijela MaricNorthwestern University, United StatesMichelle MaritzUniversity of Cape Town, South AfricaRomain MarlinImmunology of Viral Infections and Autoimmune Diseases/IDMIT Infrastructure/CEA/DRF/iMETI/Division of Immuno-Virology, Université Paris Sud, INSERM U 1184, FranceElena MartinelliPopulation Council, United StatesDavid MartinezDuke University, United StatesSylvia MasawiMedical Research Council/Uganda Virus Research Institute (UVRI), UgandaJane Humphrey MashingiaEast African Community Secretariat, TanzaniaChamunorwa MashokoInternational Partnership for Microbicides (IPM), ZimbabweLuzia MayrINSERM U1109, FMTS, Université de Strasbourg, FranceTowela MfuneZambia Emory HIV Research Project, ZambiaDieter MielkeUniversity of Cape Town, South AfricaJoseph Mogunde ObungaJaramogi Oginga Odinga Teaching and Referral Hospital, KenyaBoitumelo MokgatlaInternational AIDS Vaccine Initiative (IAVI), BotswanaLuis Manuel Molinos-AlbertAIDS Research Institute, IrsiCaixa-HIVACAT, SpainThandeka MoyoUniversity of Cape Town, South AfricaJuliet MpendoUganda Virus Research Institute (UVRI)–International AIDS Vaccine Initiative (IAVI), UgandaSteven MuchnickBridge HIV, HVTN GCAB, UCSF/SFGH ACTU CAB, ACTG GCAB, DARE CAB, Getting to Zero SF CAB, KPSF HIV Update Editorial Board, ATAC DDC, United StatesPeter MugoKEMRI Wellcome Trust, KenyaKenneth MugwanyaUniversity of Washington, United StatesLuke MuirImperial College London, United KingdomJeannine MukamuyangoProjet San Francisco (PSF)/Rwanda Zambia HIV Research Group-Emory University, RwandaErick MuokProjet San Francisco (PSF), RwandaMarianne MureithiUniversity of Nairobi, KenyaKennedy Mutai KipkoechKenya Medical Research Institute, Centre for Global Health Research, KenyaGaudensia MutuaUniversity of Nairobi, KenyaTimothy MuwongeMakerere University, UgandaKenneth MwehongeCoalition for Health Promotion and Social Development (HEPS Uganda), UgandaLawrence MwihakiPartners in Health and Research Development (PHRD), KenyaLillian MworekoInternational Community of Women Living with HIV Eastern Africa, UgandaHelga NaburiMuhimbili University of Health and Allied Sciences, TanzaniaFaith NaddungaMedical Research Council/Uganda Virus Research Institute (UVRI), UgandaKalendri NaidooCentre for the AIDS Programme of Research in South Africa (CAPRISA), South AfricaLillian Naigaga MutenguInternational AIDS Vaccine Initiative (IAVI), KenyaGonasagrie NairCentre for the AIDS Programme of Research in South Africa (CAPRISA), South AfricaJauhara NanyondoMakerere University Walter Reed Project, UgandaGertrude NanyonjoUganda Virus Research Institute (UVRI)–International AIDS Vaccine Initiative (IAVI), UgandaRobert NewellsAIDS Project of the East Bay, United StatesJane Ng'ang'aKAVI-Institute of Clinical Research, KenyaJohn Ng'ang'aUniversity of Manitoba/University of Nairobi–Kenya Aids Control Project (KACP), KenyaSinaye NgcapuCentre for the AIDS Programme of Research in South Africa (CAPRISA), South AfricaKenneth NgureJomo Kenyatta University of Agriculture and Technology, KenyaPhilip NguyenMcMaster University, CanadaMelanie NicolUniversity of Minnesota, United StatesNjambi NjugunaPartners in Health and Research Development, KenyaStella NjugunaKenya Medical Research Institute, KenyaVeronica NosedaPlanned Parenthood, FranceSupercharger Moses NsubugaJoint Clinical Research Centre, UgandaBorna Achieng NyaokeKAVI–Institute of Clinical Research, University of Nairobi, KenyaDelvin NyasaniKenya Aids Vaccine Initiative–Institute of Clinical Research, KenyaJulien NyombayireProjet San Francisco (PSF)/Rwanda Zambia HIV Research Group–Emory University, RwandaStephen OkoboiThe AIDS Support Organisation (TASO), UgandaAbiola OlaleyeAchieving Health Nigeria Initiative, NigeriaOladipupo OlaleyeUniversity of Ibadan, NigeriaKennedy OlangoMen Against AIDS Youth Group, KenyaAdeolu OluremiLadoke Akintola University of Science and Technology, NigeriaRegina OmbamNational AIDS Control Council, KenyaSimon OndiekHIV/AIDS Research & Advocacy Programme, KenyaChiara OrlandiHuman Virology Institute, University of Maryland, United StatesSophia OsaweInstitute of Human Virology, Nigeria, NigeriaTeresia OtienoATHENA Network, United StatesGeorge Victor OwinoInternational AIDS Vaccine Initiative (IAVI), KenyaGbemisola OyeneyinInitiative for Better Public Health, NigeriaThesla Palanee-PhillipsWits Reproductive Health and HIV Institute, South Africa
Referência(s)